Symbols

Symbols

CTOR

CTOR

Citius Oncology: When Will the Biotech Become Profitable?

Tuesday Oct 21, 2025

Citius Pharmaceuticals Raises $6 Million in Registered Direct Offering

Monday Oct 20, 2025

Citius Oncology Secures Distribution Agreement with McKesson to Support LYMPHIR Launch

McKesson Becomes Authorized US Distributor for LYMPHIR Cancer Treatment.

Thursday Oct 16, 2025

CCSC Technology: 15min chart triggers Bollinger Bands Narrowing, Bearish Marubozu.

Citius Oncology Partners with EVERSANA for LYMPHIR Commercialization

Citius Oncology partners with EVERSANA for LYMPHIR commercialization.

Wednesday Oct 08, 2025

Cancer Treatment Market to Reach $643.5B by 2034.

Tuesday Oct 07, 2025

Citius Oncology expands LYMPHIR availability through Named Patient Programs in Europe, Middle East.

Friday Sep 26, 2025

Citius Oncology Ownership Insights: Public Companies Dominate

Tuesday Sep 23, 2025

Citius Oncology shares surge 12.92% intraday after Maxim Group upgrades rating to 'buy' and drug LYMPHIR launch planned for Q4 2025.

Citius Oncology: Maxim Group upgrades Buy from Hold, PT at $6.

Wednesday Sep 10, 2025

Citius Oncology shares rise 3.21% after-hours after closing $9 million registered direct offering.

Citius Oncology Raises $9.0 Million in Registered Direct Offering and Concurrent Private Placement

Tuesday Sep 09, 2025

Citius Oncology Raises $9mln Through Direct Offering and Private Placement, Maxim Group LLC as Sole Placement Agent.

Citius Oncology Raises $9mln, Shares Plummet Over 5%

Monday Aug 25, 2025

Citius Oncology shares rise 2.86% intraday after deploying AI platform to support LYMPHIR launch.

Friday Aug 22, 2025

Citius Oncology Deploys AI Platform to Amplify Commercial Team Ahead of LYMPHIR Launch

Tuesday Aug 12, 2025

Citius Oncology Beats Q3 EPS Estimates with $0 Revenue

Thursday Jul 24, 2025

Citius Oncology's 15min chart shows Bollinger Bands Narrowing, Bearish Marubozu signal.